India, May 22 : Leading pharmaceutical companies announced fresh investments in research laboratories and manufacturing expansion as demand for affordable medicines and specialised treatments grows globally.
Industry executives said India continues strengthening its role as a major supplier of generic medicines and vaccine production. Regulatory compliance and quality standards remain key priorities for exporters targeting international markets.
Healthcare economists expect continued growth in pharmaceutical exports over the next few years.